-
Je něco špatně v tomto záznamu ?
DNA and RNA Binding Proteins: From Motifs to Roles in Cancer
O. Bonczek, L. Wang, SV. Gnanasundram, S. Chen, L. Haronikova, F. Zavadil-Kokas, B. Vojtesek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
Project ENOCH; CZ.02.1.01/0.0/0.0/16_019/0000868
European Regional Development Fund
GACR 19-18177Y
The Czech Science Foundation
Conceptual Development of Research Organization MMCI; 00209805
The Ministry of Health, Czech Republic
180296 and 19 0073 Pj 01 H
Cancerfonden
UPD2020-0047
The Wenner-Gren Foundation in Sweden
SMK1864
Kempe foundation
LP 21-2270
Cancerforskningsfonden Norr
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
36012592
DOI
10.3390/ijms23169329
Knihovny.cz E-zdroje
- MeSH
- DNA vazebné proteiny metabolismus MeSH
- DNA MeSH
- lidé MeSH
- nádory * genetika metabolismus MeSH
- proteiny vázající RNA * metabolismus MeSH
- RNA genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
DNA and RNA binding proteins (DRBPs) are a broad class of molecules that regulate numerous cellular processes across all living organisms, creating intricate dynamic multilevel networks to control nucleotide metabolism and gene expression. These interactions are highly regulated, and dysregulation contributes to the development of a variety of diseases, including cancer. An increasing number of proteins with DNA and/or RNA binding activities have been identified in recent years, and it is important to understand how their activities are related to the molecular mechanisms of cancer. In addition, many of these proteins have overlapping functions, and it is therefore essential to analyze not only the loss of function of individual factors, but also to group abnormalities into specific types of activities in regard to particular cancer types. In this review, we summarize the classes of DNA-binding, RNA-binding, and DRBPs, drawing particular attention to the similarities and differences between these protein classes. We also perform a cross-search analysis of relevant protein databases, together with our own pipeline, to identify DRBPs involved in cancer. We discuss the most common DRBPs and how they are related to specific cancers, reviewing their biochemical, molecular biological, and cellular properties to highlight their functions and potential as targets for treatment.
Department of Medical Biosciences Umea University 90187 Umea Sweden
Research Centre for Applied Molecular Oncology Zluty Kopec 7 656 53 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024804
- 003
- CZ-PrNML
- 005
- 20250109080432.0
- 007
- ta
- 008
- 221017s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms23169329 $2 doi
- 035 __
- $a (PubMed)36012592
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bonczek, Ondřej, $d 1986- $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden $1 https://orcid.org/0000000307453136 $7 xx0327493
- 245 10
- $a DNA and RNA Binding Proteins: From Motifs to Roles in Cancer / $c O. Bonczek, L. Wang, SV. Gnanasundram, S. Chen, L. Haronikova, F. Zavadil-Kokas, B. Vojtesek
- 520 9_
- $a DNA and RNA binding proteins (DRBPs) are a broad class of molecules that regulate numerous cellular processes across all living organisms, creating intricate dynamic multilevel networks to control nucleotide metabolism and gene expression. These interactions are highly regulated, and dysregulation contributes to the development of a variety of diseases, including cancer. An increasing number of proteins with DNA and/or RNA binding activities have been identified in recent years, and it is important to understand how their activities are related to the molecular mechanisms of cancer. In addition, many of these proteins have overlapping functions, and it is therefore essential to analyze not only the loss of function of individual factors, but also to group abnormalities into specific types of activities in regard to particular cancer types. In this review, we summarize the classes of DNA-binding, RNA-binding, and DRBPs, drawing particular attention to the similarities and differences between these protein classes. We also perform a cross-search analysis of relevant protein databases, together with our own pipeline, to identify DRBPs involved in cancer. We discuss the most common DRBPs and how they are related to specific cancers, reviewing their biochemical, molecular biological, and cellular properties to highlight their functions and potential as targets for treatment.
- 650 _2
- $a DNA $7 D004247
- 650 _2
- $a DNA vazebné proteiny $x metabolismus $7 D004268
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory $x genetika $x metabolismus $7 D009369
- 650 _2
- $a RNA $x genetika $7 D012313
- 650 12
- $a proteiny vázající RNA $x metabolismus $7 D016601
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Wang, Lixiao $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden
- 700 1_
- $a Gnanasundram, Sivakumar Vadivel $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden $1 https://orcid.org/0000000191530784
- 700 1_
- $a Chen, Sa $u Department of Medical Biosciences, Umea University, 90187 Umea, Sweden
- 700 1_
- $a Haronikova, Lucia $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Zavadil-Kokas, Filip $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic
- 700 1_
- $a Vojtesek, Borivoj $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute (MMCI), Zluty Kopec 7, 656 53 Brno, Czech Republic $1 https://orcid.org/0000000161943705
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 16 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36012592 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20250109080427 $b ABA008
- 999 __
- $a ok $b bmc $g 1854501 $s 1176094
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 23 $c 16 $e 20220818 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a Project ENOCH; CZ.02.1.01/0.0/0.0/16_019/0000868 $p European Regional Development Fund
- GRA __
- $a GACR 19-18177Y $p The Czech Science Foundation
- GRA __
- $a Conceptual Development of Research Organization MMCI; 00209805 $p The Ministry of Health, Czech Republic
- GRA __
- $a 180296 and 19 0073 Pj 01 H $p Cancerfonden
- GRA __
- $a UPD2020-0047 $p The Wenner-Gren Foundation in Sweden
- GRA __
- $a SMK1864 $p Kempe foundation
- GRA __
- $a LP 21-2270 $p Cancerforskningsfonden Norr
- LZP __
- $a Pubmed-20221017